Reno, Nevada — November 5, 2025 — Leads & Copy — Conexeu Sciences Inc., a biotechnology innovator focused on regenerative medicine, has appointed Aaron Farberg, M.D., and Sebastian Purcell, Ph.D., to its Board of Directors.
Dr. Farberg brings expertise in regenerative dermatology, while Dr. Purcell offers ethical clarity and strategic vision. Jeff Sharpe, Chairman of the Board, noted that their perspectives will help Conexeu bring collagen technologies to patients.
Dr. Farberg is a dermatologist, surgeon, and researcher. He is the Chief Medical Officer and Founding Partner Dermatologist at Bare Derm Group, Executive Director and Principal Investigator at Reveal Research Institute, and holds multiple academic appointments in Texas. He was named the #1 Dermatologist in Texas by NEWSWEEK in 2023.
Dr. Purcell, a philosopher and investor, is the CEO and CIO of 1.2 Capital. He holds a Ph.D. in Philosophy from Boston College and has lectured at Princeton, Columbia, and McGill Universities. His commentary has appeared in The Guardian, BBC World, and Time Magazine.
Miles Harrison, President, CEO, and Board Member of Conexeu Sciences, said the new members strengthen the company’s purpose. Both new Board members expressed enthusiasm about joining Conexeu.
Conexeu Sciences, founded in 2022, is advancing regenerative medicine through its patented collagen-based liquid platform. Its lead product, Ten Minute Tissue™, is an investigational product and has not been cleared or approved by any regulatory authority.
Contact: David Bogart, 1-424-333-5622 ext 7, Ir@conexeu.com
Source: Conexeu Sciences Inc.
